Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules
NCT06279533
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
LV232/Placebo
DRUG:
LV232
Sponsor
Vigonvita Life Sciences